Insulin glulisine: efficacy and safety compared with other rapid-acting insulin analogues

被引：10
|
作者：
Kamal, Ali D. [1 ]
Bain, Stephen C. [1 ]
机构：
[1] Birmingham Heartlands Hosp NHS Fdn, Birmingham B9 5SS, W Midlands, England
来源：
EXPERT OPINION ON DRUG SAFETY | 2007年 / 6卷 / 01期
关键词：
analogue insulin; hypoglycaemia; insulin glulisine;
D O I：
10.1517/14740338.6.1.5
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Glulisine insulin is the latest addition to the class of rapid-acting insulin analogues. It is important that it is comparable in safety not only to human regular insulin, but also to the well established analogue insulins, aspart and lispro. In this summary the evidence comparing the safety and efficacy of glulisine with its counterpart insulins in various groups of diabetic patients is discussed.
引用
收藏
页码：5 / 7
页数：3
相关论文
共 50 条
  • [1] Efficacy and safety of switching to insulin glulisine from other rapid-acting insulin analogs in children with type 1 diabetes
    Urakami, Tatsuhiko
    Kuwabara, Remi
    Habu, Masako
    Okuno, Misako
    Suzuki, Junichi
    Takahashi, Shori
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2015, 6 (01): : 87 - 90
  • [2] Insulin glulisine (Apidra):: A new rapid-acting insulin
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2006, 48 (1233): : 33 - 34
  • [3] Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes
    Garg, SK
    Ellis, SL
    Ulrich, H
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (04) : 643 - 651
  • [4] Rapid-acting insulin glulisine: an update on clinical experience
    Dailey, George
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (04) : 527 - 542
  • [5] Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis
    Andrade-Castellanos, Carlos A.
    Enrique Colunga-Lozano, Luis
    Delgado-Figueroa, Netzahualpilli
    Gonzalez-Padilla, Daniel A.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (01):
  • [6] Effects of rapid-acting insulin analogues insulin glulisine and insulin aspart on postprandial glycemic excursion with single bout of exercise in patients with type 2 diabetes
    Tanaka, Nagaaki
    Hiura, Yoshikazu
    [J]. ENDOCRINE JOURNAL, 2015, 62 (05) : 411 - 416
  • [7] Safety of Rapid-Acting Insulin Analogs Versus Regular Human Insulin
    Kitabchi, Abbas E.
    Gosmanov, Aidar R.
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2012, 344 (02): : 136 - 141
  • [8] Evaluation of the pharmacodynamic and pharmacokinetic profiles of insulin glulisine - a novel, rapid-acting, human insulin analogue.
    Becker, RHA
    Frick, AD
    Wessels, DH
    Scholtz, HE
    [J]. DIABETOLOGIA, 2003, 46 : A268 - A268
  • [9] The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences
    Home, P. D.
    [J]. DIABETES OBESITY & METABOLISM, 2012, 14 (09): : 780 - 788
  • [10] Rapid-Acting Insulin Analogs
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2009, 51 (1327): : 98 - 98
12345